Dr. Will Andrews joined Acer Therapeutics as Chief Medical Officer in October of 2017. He has worked in the biotech/pharmaceutical industry for 17 years in both Clinical Development and Medical Affairs, and has worked in multiple therapeutic areas, with a focus and extensive experience in rare diseases. Dr. Andrews has significant medical marketplace and product launch experience, having served as the medical lead for six product launches, including Xopenex HFA®, Brovana®, Alvesco®, Omnaris®, Catena®, and Juxtapid®. Most recently, he provided strategic consulting services to rare disease companies in Clinical Development, Medical Affairs, Go-To-Market/Launch planning, and Business Development/Corporate Strategy.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Acer Therapeutics | Chief Medical Officer | Oct 1, 2017 | — | Detail |